Do β-Blockers Cause Depression?: Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy
- PMID: 33719510
- DOI: 10.1161/HYPERTENSIONAHA.120.16590
Do β-Blockers Cause Depression?: Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy
Erratum in
-
Correction to: Do β-Blockers Cause Depression? Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy.Hypertension. 2022 Mar;79(3):e72. doi: 10.1161/HYP.0000000000000211. Epub 2022 Feb 9. Hypertension. 2022. PMID: 35138874 No abstract available.
Abstract
[Figure: see text].
Keywords: cardiovascular diseases; depression; heart failure; morbidity; mortality.
Similar articles
-
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.JAMA. 2002 Jul 17;288(3):351-7. doi: 10.1001/jama.288.3.351. JAMA. 2002. PMID: 12117400 Review.
-
Beta-blocker therapy and clinical depression.Am J Med. 1988 Mar;84(3 Pt 1):559-60. doi: 10.1016/0002-9343(88)90285-9. Am J Med. 1988. PMID: 2894767 No abstract available.
-
Do randomized controlled trials always trump case reports? A second look at propranolol and depression.Pharmacotherapy. 2006 Feb;26(2):162-7. doi: 10.1592/phco.26.2.162. Pharmacotherapy. 2006. PMID: 16466322 Review.
-
A review on the putative association between beta-blockers and depression.Heart Fail Clin. 2011 Jan;7(1):89-99. doi: 10.1016/j.hfc.2010.08.006. Heart Fail Clin. 2011. PMID: 21109212 Review.
-
Beta-blocker use and the development of depression.Am J Cardiol. 2009 May 1;103(9):1331-2. doi: 10.1016/j.amjcard.2009.02.033. Am J Cardiol. 2009. PMID: 19406286 No abstract available.
Cited by
-
Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS).BMC Pharmacol Toxicol. 2024 Nov 14;25(1):86. doi: 10.1186/s40360-024-00815-w. BMC Pharmacol Toxicol. 2024. PMID: 39543745
-
The causal relationship between antihypertensive drugs and depression: a Mendelian randomization study of drug targets.Front Endocrinol (Lausanne). 2024 Aug 9;15:1411343. doi: 10.3389/fendo.2024.1411343. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39184138 Free PMC article.
-
Depression Following Acute Coronary Syndrome: A Review.Rev Cardiovasc Med. 2023 Sep 5;24(9):247. doi: 10.31083/j.rcm2409247. eCollection 2023 Sep. Rev Cardiovasc Med. 2023. PMID: 39076389 Free PMC article. Review.
-
For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.J Hypertens. 2024 Jun 1;42(6):948-950. doi: 10.1097/HJH.0000000000003733. Epub 2024 Apr 12. J Hypertens. 2024. PMID: 38634468 Free PMC article.
-
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.Hypertension. 2024 May;81(5):1021-1030. doi: 10.1161/HYPERTENSIONAHA.124.22821. Epub 2024 Mar 13. Hypertension. 2024. PMID: 38477109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
